Excerpt

This guideline contains recommendations about general principles for managing intravenous (IV) fluids in children and young people under 16 years, and applies to a range of conditions and different settings. It does not include recommendations relating to specific conditions.

Recommendations on the management of intravenous fluids in adults (from their 16^th birthday) in hospital settings can be found in NICE clinical guideline 174 IV fluids in adults. Healthcare professionals should use their clinical judgement when managing young people transitioning between paediatric and adult services and paediatric and adult healthcare teams should work together to provide assessment and services to young people who need IV fluids. Diagnosis and management should be reviewed throughout the transition process, and there should be clarity about who is the lead clinician to ensure continuity of care.

Contents

• Guideline Development Group members
• NCGC technical team members
• Co-optees
• Acknowledgements
• 1. Introduction
• 2. Development of the guideline
  • 2.1. What is a NICE clinical guideline?
  • 2.2. Remit
  • 2.3. Who developed this guideline?
• 3. Methods
  • 3.1. Developing the review questions and outcomes
  • 3.2. Searching for evidence
  • 3.3. Evidence of effectiveness
  • 3.4. Developing recommendations
• 4. Guideline summary
  • 4.1. Algorithms for IV fluid therapy in children and young people in hospital
  • 4.2. Diagram of ongoing losses
  • 4.3. Table of intravenous fluid types
  • 4.4. Key priorities for implementation
  • 4.5. Full list of recommendations
  • 4.6. Key research recommendations
• 5. Assessment and monitoring
  • 5.1. Methods of assessing IV fluid requirements
  • 5.2. Methods of calculating IV fluid requirements
• 6. IV fluid therapy for fluid resuscitation
  • 6.1. Introduction
• 7. IV fluid therapy for routine maintenance
  • 7.1. Introduction
• 8. IV fluid therapy for replacement and redistribution
  • 8.1. Introduction
• 9. Managing hypernatraemia and hyponatraemia that develops during IV fluid administration
  • 9.1. Introduction
• 10. Training and education of healthcare professionals for management of IV fluid therapy
  • 10.1. Introduction
• 11. Reference list
• 12. Acronyms and abbreviations
• 13. Glossary
• Appendix A. Scope
• Appendix B. Declarations of interest
• Appendix C. Review protocols
• Appendix D. Clinical article selection
• Appendix E. Economic article selection
• Appendix F. Literature search strategies
• Appendix G. Clinical evidence tables
• Appendix H. Economic evidence tables
• Appendix I. GRADE tables
• Appendix J. Forest plots
• Appendix K. Excluded clinical studies
• Appendix L. Excluded economic studies
• Appendix M. Cost-sensitivity analysis: Monitoring and assessment strategies for intravenous fluid therapy in children
• Appendix N. Research recommendations
• Appendix O. NICE technical team

Disclaimer: Healthcare professionals are expected to take NICE clinical guidelines fully into account when exercising their clinical judgement. However, the guidance does not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of each patient, in consultation with the patient and, where appropriate, their guardian or carer.